Article

LncRNA antigens- a novel resource to improve immunotherapy efficacy predictions in Melanoma

2023-06-01

Abstract excerpt

<h4>Background</h4> ICI (immune checkpoint inhibitor) therapy is one of the most promising treatments for melanoma. ICI response however varies among patients, emphasizing the importance of identifying genomic biomarkers to predict likely therapeutic efficacy in advance of treatment. We hypothesised that a lncRNA based immunogencity (lnc-IM) score could be used to predict individual response to ICI treatment, and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4a35f902-35b9-5ab9-83db-65c144548a23
DOI: 10.1101/2023.05.30.23290735

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

LncRNA antigens- a novel resource to improve immunotherapy efficacy predictions in MelanomaDOI 10.1101/2023.05.30.23290735Read

LncRNA antigens - a novel resource to improve immunotherapy efficacy predictions in melanomaSemantic proximity Read

Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance MechanismsSemantic proximity Read

Construction of immune scores to predict patient prognosis and response of anti-PD1 treatment in stage III-IV melanomaSemantic proximity Read

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response RatesSemantic proximity Read

Integrated germline and somatic features reveal divergent immune pathways driving ICB responseSemantic proximity Read

Explainable machine learning identifies features and thresholds predictive of immunotherapy responseSemantic proximity Read

Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.Semantic proximity Read

MHC class I and class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanomaSemantic proximity Read

Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future PerspectivesSemantic proximity Read

The combination of single-cell and bulk RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genesSemantic proximity Read

A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironmentSemantic proximity Read

Transcriptional analysis of immune modulatory genes in melanoma treated with PD-1 blockadeSemantic proximity Read